Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh

BACKGROUND: AmBisome therapy for VL has an excellent efficacy and safety profile and has been adopted as a first-line regimen in Bangladesh. Second-line treatment options are limited and should preferably be given in short course combinations in order to prevent the development of resistant strains....

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:PLoS Negl Trop Dis
Glavni autori: Rahman, Ridwanur, Goyal, Vishal, Haque, Rashidul, Jamil, Kazi, Faiz, Abul, Samad, Rasheda, Ellis, Sally, Balasegaram, Manica, den Boer, Margriet, Rijal, Suman, Strub-Wourgaft, Nathalie, Alves, Fabiana, Alvar, Jorge, Sharma, Bhawna
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2017
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5466346/
https://ncbi.nlm.nih.gov/pubmed/28558062
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0005635
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items